US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Antibody Technologies Market Research Reports & Industry Analysis

RSS Feeds

Antibody Technologies Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Global & Usa Cancer Immunotherapy Market Analysis To 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells,
4/1/2015 | published by: Kelly Scientific Publications
... Therapy (ACT) & IDO Inhibitors This report provides a comprehensive overview of the size of cancer immunotherapy market, the segmentation of the market, key players and the vast potential of therapies that are in clinical ...  |  read more...
USD 3,400
Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 202
3/24/2015 | published by: MarketsandMarkets
... such as the China and India are lucrative markets for protein engineering, owing to increase in R&D investment by the biologics companies in these regions. The report segments the global protein engineering market product, technology, ...  |  read more...
USD 4,650
Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux
3/28/2015 | published by: La Merie Publishing
... tumors as of March 2015. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will ...  |  read more...
USD 288
Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab
3/25/2015 | published by: La Merie Publishing
... as of March 2015. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be ...  |  read more...
USD 346
Competitor Analysis: TNF Antibodies 2015– Biosimilars and Biosuperiors of Humira, Remicade and Enbrel
3/22/2015 | published by: La Merie Publishing
... its receptor used to treat various inflammatory and autoimmune diseases as of March 2015. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since ...  |  read more...
USD 577
Engineered TCR and CAR Immunotherapeutics 2015
3/11/2015 | published by: La Merie Publishing
... promising emerging technologies in immuno-oncology apart from immune checkpoint modulators. The relevance of TCR targeting and engineered T cells is reflected by impressive clinical results with CD19 chimeric antigen receptor (CAR) T cells and outstanding ...  |  read more...
USD 2,630
Antibody Deals and Alliances of 2014
3/1/2015 | published by: Current Partnering
... during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2015
3/1/2015 | published by: DelveInsight
... provides the marketed and pipeline scenario of the ADCs. The Report has covered the 264 Antibody-drug conjugates profile which gives core information of the targets, mechanism of action, development partner, Technology partner, monoclonal antibody used, ...  |  read more...
USD 3,500
Monoclonal Antibodies Partnering Terms and Agreements
2/1/2015 | published by: Current Partnering
... obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest ...  |  read more...
USD 2,995
Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin
2/15/2015 | published by: La Merie Publishing
... antibodies targeting Her2 for treatment of Her2 positive breast and gastric cancer as of February 2015. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ...  |  read more...
USD 390
Global Cancer Monoclonal Antibody Partnering 2010-2015: Deal Trends, players, financials and forecasts
3/1/2015 | published by: Current Partnering
... monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cancer monoclonal antibody partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering ...  |  read more...
USD 2,995
Prepacked Column Market by Type (1-100 mL, 100-1000 mL, >1L) - Global Forecast to 2019
2/2/2015 | published by: MicroMarketMonitor
... the factors driving the growth of pre-packed columns market. The cost-effective purification of biological drugs, specifically monoclonal antibodies (mAbs) has been increasing the market potential of pre-packed columns. However, there is a paradigm shift towards ...  |  read more...
USD 4,250
Competitor Analysis: Specific and Bispecific Her3 Antibodies
2/16/2015 | published by: La Merie Publishing
... Her3 and Her2 or EGF-R or other targets for treatment of cancer as of February 2015. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ...  |  read more...
USD 260
Global MABS Industry 2014 Market Research Report
1/10/2015 | published by: 9Dimen Research
... the main countries (United States, Germany, Japan and China). The report firstly introduced the MABS basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so ...  |  read more...
USD 2,850
Bio Products Markets in China
11/1/2014 | published by: Asia Market Information & Development Company
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic ...  |  read more...
USD 4,000
Global Markets for Research Antibodies
1/1/2015 | published by: BCC Research
... a compound annual growth rate (CAGR) of 6.2% for the period 2014-2019. This report provides: An overview of the global market for antibodies used in research. Analyses of global market trends, with data from 2013, ...  |  read more...
USD 6,650
Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019
11/3/2014 | published by: MarketsandMarkets
... such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, ...  |  read more...
USD 4,650
Anti-CD22 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD22 Antibody. This report provides information on the therapeutic development based on the Anti-CD22 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD25 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD25 Antibody. This report provides information on the therapeutic development based on the Anti-CD25 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Anti-CD274 (PD-L1) Antibody. This report provides information on the therapeutic development based on the Anti-CD274 (PD-L1) Antibody dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Anti-CD279 (PD-1) Antibody. This report provides information on the therapeutic development based on the Anti-CD279 (PD-1) Antibody dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD3 Antibody. This report provides information on the therapeutic development based on the Anti-CD3 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD38 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD38 Antibody. This report provides information on the therapeutic development based on the Anti-CD38 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD4 Antibody. This report provides information on the therapeutic development based on the Anti-CD4 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD40 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD40 Antibody. This report provides information on the therapeutic development based on the Anti-CD40 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10